REPH Message Board Post 9855520 | Recro Pharma Inc.
home / stock / reph / reph message board
jeff.pride
(investorshub)
Posted on: May/24/2018 11:18:08
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=141040438
REPH Does NOT meet primary endpoint of FDA=
News, Short Squeeze, Breakout and More Instantly...
-
Societal CDMO to be Acquired by CoreRx, Inc. to Create an Enhanced CDMO with Broad Capabilities Spanning Early-Stage Formulation Development through Commercial Manufacturing and Packaging CoreRx to Commence a Tender Offer for all Outstanding Shares of Societal CDMO, Inc. CLEARWATE...
-
Agreement Broadly Applicable to All Therapeutic Areas with Specific Focus on the Growing Psychedelic and Cannabinoid Drug Development Markets Complementary Capabilities Range from API Manufacturing through Process Development and cGMP Manufacturing to Fill/Finish GAINESVILLE, Ga. ...
-
Recorded Q3 Revenue of $23.6 Million Signed Multiple New Business Agreements with New and Existing Customers Closed Public Offering Raising Gross Proceeds of Approximately $8.3 Million Initiated Corporate Restructuring; Expected to Result in Annualized Savings of Approxi...